Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Castera

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Radiology|July 1, 2020
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH StudyAnne-Laure Hermann, Arnaud Dieudonné, Maxime Ronot, et al.
Biomedicines|December 30, 2025
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based CohortThierry Poynard, Olivier Deckmyn, Valentina Peta, et al.
Carcinogenesis|March 23, 2004
The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosisRaphaël Saffroy, Patrick Pham, Franck Chiappini, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Hepatitis B vaccination in HIV-infected patients: a survey of physicians and patients participating in the Aquitaine cohortMaria Winnock, Didier Neau, Laurent Castera, et al.
Hepatology (Baltimore, Md.)|January 14, 2009
Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis CDamien Lucidarme, Juliette Foucher, Brigitte Le Bail, et al.
The American Journal of Gastroenterology|September 18, 2008
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohortMarc-Arthur Loko, Laurent Castera, François Dabis, et al.
The Oncologist|March 22, 2014
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenibMaxime Ronot, Mohamed Bouattour, Johanna Wassermann, et al.
Journal of Viral Hepatitis|February 8, 2024
Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virusRachel L Epstein, Benjamin Buzzee, Laura F White, et al.
European Radiology|March 15, 2014
Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosisMaxime Ronot, Simon Lambert, Laure Elkrief, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2025
Effectiveness of six international guidelines using FIB-4 and FibroScan for risk stratification of MASLD in type 2 diabetesTiphaine Vidal-Trécan, Jean-Baptiste Julla, Tania El Khoury, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Radiology|July 1, 2020
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with <sup>90</sup>Y in the SARAH StudyAnne-Laure Hermann, Arnaud Dieudonné, Maxime Ronot, et al.
Biomedicines|December 30, 2025
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based CohortThierry Poynard, Olivier Deckmyn, Valentina Peta, et al.
Carcinogenesis|March 23, 2004
The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosisRaphaël Saffroy, Patrick Pham, Franck Chiappini, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Hepatitis B vaccination in HIV-infected patients: a survey of physicians and patients participating in the Aquitaine cohortMaria Winnock, Didier Neau, Laurent Castera, et al.
Hepatology (Baltimore, Md.)|January 14, 2009
Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis CDamien Lucidarme, Juliette Foucher, Brigitte Le Bail, et al.
The American Journal of Gastroenterology|September 18, 2008
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohortMarc-Arthur Loko, Laurent Castera, François Dabis, et al.
The Oncologist|March 22, 2014
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenibMaxime Ronot, Mohamed Bouattour, Johanna Wassermann, et al.
Journal of Viral Hepatitis|February 8, 2024
Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virusRachel L Epstein, Benjamin Buzzee, Laura F White, et al.
European Radiology|March 15, 2014
Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosisMaxime Ronot, Simon Lambert, Laure Elkrief, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2025
Effectiveness of six international guidelines using FIB-4 and FibroScan for risk stratification of MASLD in type 2 diabetesTiphaine Vidal-Trécan, Jean-Baptiste Julla, Tania El Khoury, et al.
Pageof 21